Novo Nordisk a S: Form 20-F for the period ended Dec 31, 2021
Filed with the SEC on Feb 2, 2022 and accepted by EDGAR at Feb 2, 2022, 09:06 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-01-01 to 2021-12-31 | DKK 140.80bn | ifrs-full:Revenue |
| Cost of revenue | 12 months2021-01-01 to 2021-12-31 | DKK 23.66bn | ifrs-full:CostOfSales |
| Gross profit | 12 months2021-01-01 to 2021-12-31 | DKK 117.14bn | ifrs-full:GrossProfit |
| Operating income | 12 months2021-01-01 to 2021-12-31 | DKK 58.64bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2021-01-01 to 2021-12-31 | DKK 11.32bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2021-01-01 to 2021-12-31 | DKK 47.76bn | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months2021-01-01 to 2021-12-31 | DKK 20.74 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2021-01-01 to 2021-12-31 | DKK 20.79 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2021-01-01 to 2021-12-31 | DKK 55.00bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2021-01-01 to 2021-12-31 | DKK 6.33bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2021-12-31 | DKK 10.72bn | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2021-12-31 | DKK 85.59bn | ifrs-full:CurrentAssets |
| Total assets | At period end2021-12-31 | DKK 194.51bn | ifrs-full:Assets |
| Current liabilities | At period end2021-12-31 | DKK 99.52bn | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2021-12-31 | DKK 123.76bn | ifrs-full:Liabilities |
| Shareholders' equity | At period end2021-12-31 | DKK 70.75bn | ifrs-full:Equity |
Source: SEC EDGAR, the filing index for accession 0001628280-22-001639. Last ingested by Listed: Oct 26, 2026, 12:35 ET. Listed shows no prices and gives no investment advice.